AAIPharma Services, Cambridge Major Laboratories Name Executive VP - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

AAIPharma Services, Cambridge Major Laboratories Name Executive VP



AAIPharma Services, a provider of pharmaceutical analytical testing, product development, and manufacturing services, and Cambridge Major Laboratories, a provider of pharmaceutical API development and manufacturing, have appointed Jeff Yuen as executive vice-president, global quality. Yuen has served as food and drug investigator at the State of California’s, Department of Health Services and was a Commander in the US Public Health Service at FDA. He also was GMP auditor, GMP advisor or FDA advisory committee member at National Nutritional Foods Association, Dietary Supplement, and BIOCOM. After leaving the FDA, he led an independent firm focused on FDA compliance and regulatory consulting for the dietary supplement, pharmaceutical, and biotechnology industries.

Source:AAIPharma Services

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality

Click here